eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.consider making a donation to support the coverage that shapes the face of berkeley.
.
for the next several days, with relatives keeping a constant vigil, robert held the hand of his wife, who was hooked up to an iv and lethargic from pain medication.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.